Orange Health Service
Orange, New South Wales 2800
5 studies enrolling now · 12 studies all time
What they study most
Advanced Hematologic Tumors, Advanced Solid Tumors, Breast Cancer, Cancer Harboring BRAF Alterations, Cancer of the Prostate, Cardiovascular Disease, Community-acquired Pneumonia, Influenza, COVID-19, First Line Non-Small Cell Lung Cancer, HGG, Hormone Sensitive Prostate Cancer, LGG, Malignant Pleural Mesothelioma
Studies at this site
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
- This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
- A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
- Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
- PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
- A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors — Stopped early
- Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104). — Running, not enrolling
- Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer — Running, not enrolling
- DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma — Completed
- A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
- Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed